サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451896

認知および記憶増強薬市場レポート：製品、用途、地域別、2024-2032

Cognitive and Memory Enhancer Drugs Market Report by Product (Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and Others), Application (Disease Treatment, Athletic Performance, Academic Performance, and Others), and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 139 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
認知および記憶増強薬市場レポート：製品、用途、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の認知および記憶増強薬市場規模は2023年に58億7,420万米ドルに達しました。今後、IMARC Groupは、2024～2032年の成長率（CAGR）は5.06%で、2032年には92億8,610万米ドルに達すると予測しています。認知障害の新興国市場の拡大、新規化合物や製剤を探索する研究開発活動の活発化、新規薬剤や革新的なドラッグデリバリー手法の導入などが、市場を牽引する主な要因です。

認知および記憶増強薬は、向精神薬やスマート・ドラッグとも呼ばれ、記憶力、注意力、創造力、総合的な精神能力などの認知機能を改善することを目的としています。これらの医薬品は、脳の活動を強化し、より優れた認知能力を促進するように設計されています。特定の病状に対して処方されるほか、市販薬（OTC）や栄養補助食品としてオンラインで購入することもできます。脳内の特定の神経伝達物質の放出を増加させることで、覚醒度と集中力を高める。また、記憶や学習に重要なアセチルコリンレベルも高める。抗酸化物質や抗炎症物質として作用し、脳を損傷から守り、最適な脳機能を促進します。また、明晰な思考を促し、認知処理速度を向上させ、意思決定能力を高める。短期記憶と長期記憶を向上させ、情報の想起と保持を容易にします。また、生産性、効率性、認知能力を高めることで、学業や仕事のパフォーマンスを向上させることもできます。

認知および記憶増強薬の市場動向：

現在、アルツハイマー病、認知症、注意欠陥多動性障害（ADHD）などの認知障害の有病率の上昇は、市場の成長を支える重要な要因の一つです。これに加えて、人々は脳の健康管理に積極的になり、認知能力を高める方法を求めるようになっており、これが認知および記憶増強薬の需要を刺激しています。さらに、認知機能や記憶力を高めることができる新しい化合物や製剤を探求する研究開発（R&D）活動が活発化していることも、市場の成長を後押ししています。これに伴い、新規薬剤や革新的なデリバリー方法の開拓が消費者の選択肢の幅を広げ、市場の成長を強化しています。また、高齢者人口の増加に伴い、加齢に伴う認知機能の低下や記憶力の低下を緩和する薬剤に対する需要が高まっていることも、市場の見通しを良好なものにしています。これとは別に、学業や職業上のパフォーマンス向上を求める学生や専門家の間で認知・記憶力増強剤の採用が増加していることは、業界の投資家にとって有利な成長機会を生み出しています。さらに、オンラインやオフラインの流通チャネルを通じて認知および記憶増強薬が広く入手可能であることが、市場の成長を強化しています。

本レポートで扱う主な質問

  • 認知および記憶増強薬の世界市場はこれまでどのように推移してきたか？
  • 世界の認知および記憶増強薬市場の促進要因、抑制要因、機会は何か？
  • それぞれの促進要因、抑制要因、機会が世界の認知および記憶増強薬市場に与える影響は？
  • 主要な地域市場は？
  • 最も魅力的な認知および記憶増強薬市場はどの国か？
  • 製品別の市場内訳は？
  • 認知および記憶増強薬市場で最も魅力的な製品は？
  • 用途別の市場内訳は？
  • 認知および記憶増強薬市場で最も魅力的な用途は？
  • 世界の認知および記憶増強薬市場の競争構造は？
  • 世界の認知および記憶増強薬市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 認知および記憶増強薬の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • アリセプト
    • 市場動向
    • 市場予測
  • エクセロン
    • 市場動向
    • 市場予測
  • ナメンダ
    • 市場動向
    • 市場予測
  • ラザダイン
    • 市場動向
    • 市場予測
  • プロビジル
    • 市場動向
    • 市場予測
  • リタリン
    • 市場動向
    • 市場予測
  • アデロール
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 疾患治療
    • 市場動向
    • 市場予測
  • 運動能力
    • 市場動向
    • 市場予測
  • 学習能力
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 促進要因・抑制要因・機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AbbVie Inc.
    • Biogen Inc.
    • Eisai Co Ltd.
    • Novartis AG
    • Takeda Pharmaceutical Company Ltd.
図表

List of Figures

  • Figure 1: Global: Cognitive and Memory Enhancer Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Cognitive and Memory Enhancer Drugs (Aricept) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Cognitive and Memory Enhancer Drugs (Aricept) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Cognitive and Memory Enhancer Drugs (Exelon) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Cognitive and Memory Enhancer Drugs (Exelon) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Cognitive and Memory Enhancer Drugs (Namenda) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Cognitive and Memory Enhancer Drugs (Namenda) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Cognitive and Memory Enhancer Drugs (Razadyne) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Cognitive and Memory Enhancer Drugs (Razadyne) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Cognitive and Memory Enhancer Drugs (Provigil) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Cognitive and Memory Enhancer Drugs (Provigil) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Cognitive and Memory Enhancer Drugs (Ritalin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Cognitive and Memory Enhancer Drugs (Ritalin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Cognitive and Memory Enhancer Drugs (Adderall) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Cognitive and Memory Enhancer Drugs (Adderall) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Cognitive and Memory Enhancer Drugs (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Cognitive and Memory Enhancer Drugs (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Cognitive and Memory Enhancer Drugs (Disease Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Cognitive and Memory Enhancer Drugs (Disease Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Cognitive and Memory Enhancer Drugs (Athletic Performance) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Cognitive and Memory Enhancer Drugs (Athletic Performance) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Cognitive and Memory Enhancer Drugs (Academic Performance) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Cognitive and Memory Enhancer Drugs (Academic Performance) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Cognitive and Memory Enhancer Drugs (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Cognitive and Memory Enhancer Drugs (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia-Pacific: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia-Pacific: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market: Breakup by Country (in %), 2023
  • Figure 79: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Global: Cognitive and Memory Enhancer Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 81: Global: Cognitive and Memory Enhancer Drugs Industry: Value Chain Analysis
  • Figure 82: Global: Cognitive and Memory Enhancer Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cognitive and Memory Enhancer Drugs Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Cognitive and Memory Enhancer Drugs Market: Competitive Structure
  • Table 6: Global: Cognitive and Memory Enhancer Drugs Market: Key Players
目次
Product Code: SR112024A8341

The global cognitive and memory enhancer drugs market size reached US$ 5,874.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 9,286.1 Million by 2032, exhibiting a growth rate (CAGR) of 5.06% during 2024-2032. The growing prevalence of cognitive disorders, increasing research and development (R&D) activities to explore new compounds and formulations, and introduction of novel drugs and innovative delivery methods represent some of the key factors driving the market.

Cognitive and memory enhancer drugs, also known as nootropics or smart drugs, aim to improve cognitive function like memory, attention, creativity, and overall mental performance. These drugs are designed to enhance brain activity and promote better cognitive abilities. They are available by prescription for specific medical conditions and can be purchased over the counter (OTC) or online as dietary supplements. They enhance alertness and focus by increasing the release of certain neurotransmitters in the brain. They also boost acetylcholine levels, which is important for memory and learning. They act as antioxidants or anti-inflammatory agents, protecting the brain from damage and promoting optimal brain function. They can also promote clearer thinking and improve cognitive processing speed and lead to better decision-making abilities. They assist in improving short-term and long-term memory, which makes it easier to recall and retain information. They also aid in enhancing academic or work performance by increasing productivity, efficiency, and cognitive abilities.

Cognitive and Memory Enhancer Drugs Market Trends:

At present, the rising prevalence of cognitive disorders, such as Alzheimer's disease, dementia, and attention deficit hyperactivity disorder (ADHD), represents one of the key factors supporting the growth of the market. Besides this, people are becoming more proactive in taking care of their brain health and seeking ways to enhance their cognitive abilities, which is catalyzing the demand for cognitive and memory enhancer drugs. Moreover, increasing research and development (R&D) activities to explore new compounds and formulations that can enhance cognitive functions and memory is propelling the growth of the market. In line with this, the development of novel drugs and innovative delivery methods is expanding the range of options available to consumers, which is strengthening the growth of the market. In addition, the growing demand for drugs that can alleviate age-related cognitive decline and memory loss due to the rising elderly population is offering a favorable market outlook. Apart from this, the increasing adoption of cognitive and memory enhancer drugs among students and professionals seeking improved academic and professional performance is creating lucrative growth opportunities for industry investors. Additionally, the wide availability of cognitive and memory enhancer drugs through online and offline distribution channels is strengthening the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cognitive and memory enhancer drugs market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product and application.

Product Insights:

Aricept

Exelon

Namenda

Razadyne

Provigil

Ritalin

Adderall

Others

The report has provided a detailed breakup and analysis of the cognitive and memory enhancer drugs market based on the type. This includes Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and others. According to the report, Aricept represented the largest segment.

Application Insights:

Disease Treatment

Athletic Performance

Academic Performance

Others

A detailed breakup and analysis of the cognitive and memory enhancer drugs market based on the application has also been provided in the report. This includes disease treatment, athletic performance, academic performance, and others. According to the report, disease treatment accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cognitive and memory enhancer drugs. Some of the factors driving the North America cognitive and memory enhancer drugs market included the growing elderly population, increasing need to enhance focus, memory, and overall cognitive abilities, development of novel drugs, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global cognitive and memory enhancer drugs market. Detailed profiles of all major companies have been provided. Some of the companies covered include AbbVie Inc., Biogen Inc., Eisai Co Ltd., Novartis AG, Takeda Pharmaceutical Company Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global cognitive and memory enhancer drugs market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global cognitive and memory enhancer drugs market?
  • What is the impact of each driver, restraint, and opportunity on the global cognitive and memory enhancer drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive cognitive and memory enhancer drugs market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the cognitive and memory enhancer drugs market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the cognitive and memory enhancer drugs market?
  • What is the competitive structure of the global cognitive and memory enhancer drugs market?
  • Who are the key players/companies in the global cognitive and memory enhancer drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cognitive and Memory Enhancer Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Aricept
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Exelon
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Namenda
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Razadyne
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Provigil
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Ritalin
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Adderall
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Disease Treatment
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Athletic Performance
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Academic Performance
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AbbVie Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Biogen Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Eisai Co Ltd.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Novartis AG
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Takeda Pharmaceutical Company Ltd.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.